Norges Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-960,504
| Closed | -$65.4M | – | 2214 |
|
|
2022
Q3 | $65.4M | Buy |
960,504
+387,709
| +68% | +$26.4M | 0.02% | 662 |
|
|
2022
Q2 | $18.3M | Buy |
572,795
+43,205
| +8% | +$1.38M | ﹤0.01% | 1287 |
|
|
2022
Q1 | $18.3M | Buy |
529,590
+327,469
| +162% | +$11.3M | ﹤0.01% | 1441 |
|
|
2021
Q4 | $5.92M | Sell |
202,121
-165,657
| -45% | -$4.85M | ﹤0.01% | 1891 |
|
|
2021
Q3 | $9.37M | Hold |
367,778
| – | – | ﹤0.01% | 1789 |
|
|
2021
Q2 | $12.9M | Sell |
367,778
-79,948
| -18% | -$2.8M | ﹤0.01% | 1705 |
|
|
2021
Q1 | $18.2M | Sell |
447,726
-106,558
| -19% | -$4.34M | ﹤0.01% | 1587 |
|
|
2020
Q4 | $24M | Buy |
554,284
+3,744
| +0.7% | +$162K | 0.01% | 1460 |
|
|
2020
Q3 | $30.4M | Buy |
550,540
+7,517
| +1% | +$414K | 0.01% | 1158 |
|
|
2020
Q2 | $34.3M | Sell |
543,023
-96,059
| -15% | -$6.06M | 0.01% | 1099 |
|
|
2020
Q1 | $32.7M | Hold |
639,082
| – | – | 0.01% | 933 |
|
|
2019
Q4 | $50.8M | Buy |
639,082
+13,190
| +2% | +$1.05M | 0.01% | 909 |
|
|
2019
Q3 | $30.4M | Hold |
625,892
| – | – | 0.01% | 1199 |
|
|
2019
Q2 | $32.9M | Buy |
625,892
+76,943
| +14% | +$4.05M | 0.01% | 1160 |
|
|
2019
Q1 | $29.1M | Buy |
548,949
+114,690
| +26% | +$6.07M | 0.01% | 1236 |
|
|
2018
Q4 | $17.8M | Buy |
434,259
+172,564
| +66% | +$7.08M | 0.01% | 1470 |
|
|
2018
Q3 | $9.95M | Hold |
261,695
| – | – | ﹤0.01% | 1820 |
|
|
2018
Q2 | $11.8M | Buy |
261,695
+11,087
| +4% | +$501K | ﹤0.01% | 1760 |
|
|
2018
Q1 | $12.1M | Buy |
+250,608
| New | +$12.1M | ﹤0.01% | 1679 |
|
|
2016
Q4 | – | Sell |
-48,600
| Closed | -$1.07M | – | 2177 |
|
|
2016
Q3 | $1.07M | Sell |
48,600
-11,400
| -19% | -$251K | ﹤0.01% | 2039 |
|
|
2016
Q2 | $995K | Buy |
+60,000
| New | +$995K | ﹤0.01% | 2066 |
|